Lenexa retiree goes above and beyond to support dementia research at KU Alzheimer’s Disease Research Center

2022 Citizen Scientist Champion Award Elevated Honoree, Bob Deady, was featured in the KU ADRC publication for his dedication to Alzheimer’s research. There’s a familiar face around the University of Kansas Alzheimer’s Disease Research Center (KU ARDC). He doesn’t have an office, or a nameplate on the door or letters behind his name. But he’s doing his […]

Read more »

Mr. President, do the right thing for Alzheimer’s patients

GAP President John Dwyer wrote an op-ed in the Dallas Examiner calling on President Biden to reverse the Centers for Medicare and Medicaid Services to cover Leqembi and future Alzheimer’s drugs and treatments. The Biden administration has a big problem on its hands. It’s sending mixed signals on new Food and Drug Administration approved Alzheimer’s […]

Read more »

Caring for loved ones with Alzheimer’s, heavy burden for Hispanic families

by Barbara Campos – Telemundo According to the conclusions of a new Alzheimer’s Association report, Hispanics are almost twice as at risk as other demographic groups, and caring for patients can place a heavy burden on households. The report illustrates the need to allocate more resources and efforts to raise awareness about a degenerative disease […]

Read more »

New Treatment for Alzheimer’s disease available, but Medicare denies unrestricted coverage for it

BAY VILLAGE, Ohio — There are two newly-approved treatments to treat Alzheimer’s Disease, but getting them covered by medicare is a battle. Alzheimer’s impacts nearly 6 million Americans over the age of 65, and that number is expected to triple by 2060. It is the sixth leading cause of death in the U.S., according to […]

Read more »

Battling The Silent Alzheimer’s EPIDEMIC in The Black Community with Roland Martin

/

GAP Associate Director of Recruitment & Strategic Initiatives, Dr. Tamiko MaGee Rodgers, was featured on the Roland Martin Unfiltered Daily Digital Show and spoke about Alzheimer’s disease clinical trials.

Read more »

Medicare Alzheimer’s Coverage Policy Advancing Clinical Trial Diversity Efforts

/

GAP President John Dwyer spoke with Cathy Kelly of Pink Sheet about the Bio-Hermes study, the necessity for diversity in #Alzheimers clinical trials, and how industry-sponsored trials are out pacing government-sponsored trials.  Although Alzheimer’s stakeholders are dismayed by the treatment access restrictions imposed by the Medicare national coverage determination last spring, the policy has also jumpstarted […]

Read more »

An Alzheimer’s Dx Comparison Study Wraps Up, Researchers Plan to Add Genomic Proteomic Profiling

/

GAP President, John Dwyer, spoke to Genome Web about the closing of our Bio-Hermes study, and what the results may do for the future of Alzheimer’s research. The Global Alzheimer’s Platform (GAP) has completed a first-of-its-kind cross sectional study comparing the performance of Alzheimer’s diagnostic assays. Topline results are expected in July of next year, […]

Read more »

Left Out for too Long: New Alzheimer’s Research Focuses on Latinos

/

GAP-Net site, El Faro Health & Therapetuics was featured in AARP on the work they are doing to bring Alzheimer’s research to the Latino and Starr County communities. On a gloomy mid-November morning in 2021, Jessica Cantú stood in the parking lot outside a health center in the rural border community of Starr County, Texas, […]

Read more »

Mobile Research Unit Increases Access to Alzheimer’s Clinical Trials for Floridians

/

In honor of World Alzheimer’s Day, the Global Alzheimer’s Platform Foundation continues to push for diversity in Alzheimer’s clinical trials WASHINGTON, DC, Sept. 20, 2022 — In recognition of World Alzheimer’s Day (Sept. 21), the Global Alzheimer’s Platform Foundation (GAP) is bringing its mobile research unit into Orlando-area communities. This continues GAP’s work toward increasing participation of […]

Read more »

GAP President John Dwyer: “It’s the size of the community of [Alzheimer’s] patients” that led to unprecedented CMS decision?

/

GAP President John Dwyer spoke with Duane Schulthess on the Vital Health podcast about everything from the work that GAP is doing with the Davos Alzheimer’s Collaborative and the CEOI and the CMS decision several months ago. “It’s just a fact that there are a lot of us that are sick with Alzheimer’s. It is the […]

Read more »

Local Startup and Clinical Researchers Come Together Over Power Meal to Discuss Memory Mapping

GAP-Net Site, iResearch Atlanta, hosted an event to brainstorm ways to educate community members on Alzheimer’s and other dementia related diseases. Near the end of July, 10 individuals from the Global Alzheimer’s Platform Foundation (GAP), MapHabit, Collaborative Real Estate, and 250 E Ponce’s very own iResearch Atlanta were exclusively invited to gather over complimentary lunch […]

Read more »

Genentech Didn’t Get it Right on Diversity for Critical Graduate Alzheimer’s Program. They’re Trying Again

/

GAP partner, Genetech, is working with us on our Bio-Hermes study to increase diversity in Alzheimer’s clinical trials. Missing a trial goal in Alzheimer’s disease is a pretty common occurrence—see crenezumab, for the latest. But Genentech’s latest reported miss was something different. The Roche unit wanted to build a clinical trial program for its lead candidate […]

Read more »

Marathon Man of Alzheimer’s Research Eyes Finish Line

Dr. Richard Holub from GAP-Net site Neurological Associates of Albany talks about his commitment to finding a cure for Alzheimer’s disease and says he won’t be retiring anytime soon. Dr. Richard Holub has spent the past 40 years dedicated to Alzheimer’s research. He has treated thousands of Alzheimer’s patients and completed more than 125 clinical […]

Read more »

GAP Launches Mobile Health Site for Clinical Trials

Individuals who are usually at risk of developing Alzheimer’s can take part in pre-screening visits at every mobile site stop. Global Alzheimer’s Platform Foundation (GAP) has introduced a new mobile health site to lower barriers to the participation of underrepresented communities in Alzheimer’s clinical trials. Around 1% of the African Americans and Hispanics with Alzheimer’s take part […]

Read more »

Brigham and Women’s Hospital Hopes to Recruit At-Risk Residents for Global Alzheimer’s Study

GAP-Net Site Brigham and Women’s Hospital Center for Alzheimer Research & Treatment (CART), was featured in their local news station about the importance of volunteer participation in clinical research. A local hospital is now part of a global effort to test a drug that may delay the devastating impact of Alzheimer’s disease. The progressive neurological […]

Read more »

Alzheimer’s Researchers Probe New Treatment Paths

GAP President John Dwyer was quoted in the Wall Street Journal speaking about how the Centers for Medicare and Medicaid Services coverage decision limits Alzheimer’s patients. The commercial failure of Biogen Inc.’s drug Aduhelm is putting new focus on the state of research into the causes of Alzheimer’s disease. More than six million people in the U.S. are […]

Read more »

Local Alzheimer’s Center Stands at Forefront of New Treatment Trial

GAP-Net Site, Neurological Associates of Albany, was featured in the news about a new trial they are participating in. Over the last five years, Jim Manuel says he slowly started to lose bits and pieces of his life. Pieces so small, it was easy for his wife and kids to think he was imagining it. […]

Read more »

New Alzheimer’s Research Center Targets Patients in the Rio Grande Valley

GAP-Net Site El Faro Health and Therapeutics’ Dr. James Falcon was interviewed about the new research center. Starr County, a rural area along the Texas-Mexico border, has one of the highest rates of Alzheimer’s disease in the country. It’s not clear why. But physicians at a new research and treatment center in the area hope to […]

Read more »

Drilling Down into the CMS Aduhelm Decision—A Primer

/

GAP President John Dwyer was quoted in AlzForum about the Centers for Medicare and Medicaid Services (CMS) National Coverage Decision (NCD) to only cover the drug Aduhlem for those in enrolled in a qualifying clinical trial. The verdict is in—but what now? The Centers for Medicare and Medicaid Services will only cover aducanumab in the context of […]

Read more »

Clinical Trial Hoping to Speed Up Alzheimer’s Diagnoses for Minorities

/

GAP President John Dwyer spoke about the Bio-Hermes study and why enrolling minority populations are a priority. Metro Orlando clinical trial hopes to speed up Alzheimer’s diagnoses for minorities Black people are twice as likely as white people to develop Alzheimer’s disease — Latinx people, 1.5 times as likely. But barriers including access to health […]

Read more »

‘Little Hollywood’ Gives Alzheimer’s a Close-up

GAP-Net sites Baylor College of Medicine Alzheimer’s Disease and Memory Disorders Center and the Lou Ruvo Center for Brain Health at the Cleveland Clinic in Las Vegas are collaborating on a film project to bring awareness of the prevalence of Alzheimer’s disease in the Latino community. Assistant director Aaron Thomas slams the clapperboard Saturday to […]

Read more »

Alzheimer’s, Dementia Rate High in South Texas

/

GAP-Net site El Faro Health & Therapeutics was featured in the Houston Chronicle. The disease took Noemi Fleming’s elderly mother slowly, the first hints in repeated anecdotes or phrases. Then misplaced keys and bills. Then, Fleming caught her mother walking outside in the middle of the night, looking for the newspaper. “Mama, it’s 1 o’clock […]

Read more »

Medicare Alzheimer’s Drug Study Criteria Would Be Out Of Reach In Many States 

GAP President John Dwyer was quoted in Pink Sheet in regard to the Centers for Medicare and Medicaid Services’ proposed National Coverage Decision. The Centers for Medicare and Medicaid Services’ proposed eligibility criteria for the research sites capable of conducting clinical trials for monoclonal antibody drugs for Alzheimer’s disease could be met in just 28 […]

Read more »

‘Rally For Access’ Video

/

GAP President John Dwyer, on behalf of the organization, joined other Alzheimer’s advocates in Washington D.C. for the ‘Rally for Access’ on March 15, 2022. The ‘Rally for Access’ gathered these organizations to remind the public what is at stake if the Centers for Medicare and Medicaid Services (CMS) National Coverage Determination (NCD) is accepted. […]

Read more »
To top